Stockreport

Septerna Highlights Pipeline Progress and Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]

Septerna, Inc.  (SEPN) 
PDF Septerna, Inc. Compelling Phase 1 Data for SEP-631 (MRGPRX2 NAM) in Healthy Volunteers Support Phase 2b Development, Initially in Chronic Spontaneous Urticaria (CSU) [Read more]